Federal Register / Vol. 74, No. 130 / Thursday, July 9, 2009 / Notices 32953 

online and in CD and printed form. The 

2010 report, which the Commission 

plans to publish in June 2010, will cover 

cross-border trade for the period ending 

in 2008 and transactions by affiliates 

based outside the country of their parent 

firm for the period ending in 2007. The 

Commission is inviting interested 

members of the public to furnish 

information in connection with the 2010 

report. 

DATES: October 13, 2009: Deadline for 

filing written submissions of 

information to the Commission. June 30, 

2010: Anticipated date for publishing 

the report. 

ADDRESSES: All Commission offices are 

located in the United States 

International Trade Commission 

Building, 500 E Street, SW., 

Washington, DC. All written 

submissions should be addressed to the 

Secretary, United States International 

Trade Commission, 500 E Street, SW., 

Washington, DC 20436. The public 

record for this investigation may be 

viewed on the Commission’s electronic 

docket (EDIS) at https://edis.usitc.gov/ 

edis3-internal/app. 

FOR FURTHER INFORMATION CONTACT: 

Project Leader Samantha Brady (202– 

205–3459 or samantha.brady@usitc.gov) 

or Services Division Chief Richard 

Brown (202–205–3438 or 

richard.brown@usitc.gov) for 

information specific to this 

investigation. For information on the 

legal aspects of these investigations, 

contact William Gearhart of the 

Commission’s Office of the General 

Counsel (202–205–3091 or 

william.gearhart@usitc.gov). The media 

should contact Margaret O’Laughlin, 

Office of External Relations (202–205– 

1819 or margaret.olaughlin@usitc.gov). 

Hearing-impaired individuals may 

obtain information on this matter by 

contacting the Commission’s TDD 

terminal at 202–205–1810. General 

information concerning the Commission 

may also be obtained by accessing its 

Internet server (http://www.usitc.gov). 

Persons with mobility impairments who 

will need special assistance in gaining 

access to the Commission should 

contact the Office of the Secretary at 

202–205–2000. 

Background: Under this investigation, 

the Commission publishes two annual 

reports, one on services trade (Recent 

Trends in U.S. Services Trade), and a 

second on merchandise trade (Shifts in 

U.S. Merchandise Trade). The latest 

version of the Commission’s Recent 

Trends in U.S. Services Trade is now 

available online at http://www.usitc.gov; 

it is also available in CD and printed 

form from the Office of the Secretary at 

202–205–2000 or by fax at 202–205– 

2104. 

The initial notice of institution of this 

investigation was published in the 

Federal Register on September 8, 1993 

(58 FR 47287) and provided for what is 

now the report on merchandise trade. 

The Commission expanded the scope of 

the investigation to cover services trade 

in a separate report, which it announced 

in a notice published in the Federal 

Register of December 28, 1994 (59 FR 

66974). The separate report on services 

trade has been published annually since 

1996, except in 2005. As in past years, 

the report will summarize trade in 

services in the aggregate and provide 

analyses of trends and developments in 

selected services during the latest 

period for which data are published by 

the U.S. Department of Commerce, 

Bureau of Economic Analysis (for the 

2010 report, data for the periods 

described above). The 2010 report will 

focus on selected infrastructure services, 

alternating with the focus of the 2009 

report on business and professional 

services. 

Written Submissions: Interested 

parties are invited to submit written 

statements and other information 

concerning the matters to be addressed 

by the Commission in its report on this 

investigation. Submissions should be 

addressed to the Secretary. To be 

assured of consideration by the 

Commission, written submissions 

related to the Commission’s report 

should be submitted at the earliest 

practical date and should be received 

not later than 5:15 p.m., October 13, 

2009. All written submissions must 

conform with the provisions of section 

201.8 of the Commission’s Rules of 

Practice and Procedure (19 CFR 201.8). 

Section 201.8 requires that a signed 

original (or a copy so designated) and 

fourteen (14) copies of each document 

be filed. In the event that confidential 

treatment of a document is requested, at 

least four (4) additional copies must be 

filed, in which the confidential 

information must be deleted (see the 

following paragraph for further 

information regarding confidential 

business information). The 

Commission’s rules authorize filing 

submissions with the Secretary by 

facsimile or electronic means only to the 

extent permitted by section 201.8 of the 

rules (see Handbook for Electronic 

Filing Procedures, http://www.usitc.gov/ 

secretary/fed_reg_notices/rules/ 

documents/ 

handbook_on_electronic_filing.pdf). 

Persons with questions regarding 

electronic filing should contact the 

Secretary (202–205–2000). 

Any submissions that contain 

confidential business information (CBI) 

must also conform with the 

requirements of section 201.6 of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.6). Section 201.6 

of the rules requires that the cover of the 

document and the individual pages be 

clearly marked as to whether they are 

the ‘‘confidential’’ or ‘‘non-confidential’’ 

version, and that the confidential 

business information be clearly 

identified by means of brackets. All 

written submissions, except for 

confidential business information, will 

be made available for inspection by 

interested parties. 

The Commission intends to prepare 

only a public report in this 

investigation. The report that the 

Commission makes available to the 

public will not contain confidential 

business information. Any confidential 

business information received by the 

Commission in this investigation and 

used in preparing the report will not be 

published in a manner that would 

reveal the operations of the firm 

supplying the information. 

By order of the Commission. 

Issued: July 6, 2009. 

Marilyn R. Abbott, 

Secretary to the Commission. 

William R. Bishop, 

Acting Secretary to the Commission. 

[FR Doc. E9–16276 Filed 7–8–09; 8:45 am] 

BILLING CODE 7020–02–P 

JUDICIAL CONFERENCE OF THE 

UNITED STATES 

Meeting of the Judicial Conference 

Advisory Committee on Rules of Civil 

Procedure 

AGENCY: Judicial Conference of the 

United States Advisory Committee on 

Rules of Civil Procedure. 

ACTION: Notice of Open Meeting. 

SUMMARY: The Advisory Committee on 

Rules of Civil Procedure will hold a 

two-day meeting. The meeting will be 

open to public observation but not 

participation. 

DATES: October 8–9, 2009. 

Time: 8:30 a.m. to 5 p.m. 

ADDRESSES: Georgetown University Law 

Center, 600 New Jersey Avenue, NW., 

Washington, DC 20001. 

FOR FURTHER INFORMATION CONTACT: John 

K. Rabiej, Chief, Rules Committee 

Support Office, Administrative Office of 

the United States Courts, Washington, 

DC 20544, telephone (202) 502–1820. 


rmajette on DSK29S0YB1 with NOTICES
32954 Federal Register / Vol. 74, No. 130 / Thursday, July 9, 2009 / Notices 

Dated: July 1, 2009. 

John K. Rabiej, 

Chief, Rules Committee Support Office. 

[FR Doc. E9–16018 Filed 7–8–09; 8:45 am] 

BILLING CODE 2210–55–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2), authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

Code of Federal Regulations (CFR), 

1301.34(a), this is notice that on 

February 13, 2009, Rhodes 

Technologies, 498 Washington Street, 

Coventry, Rhode Island 02816, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Raw Opium (9600) ....................... II 

Concentrate of Poppy Straw 

(9670) ........................................ II 

The company plans to import narcotic 

raw materials to be used in ancillary 

activities including product 

development and analytical studies. 

No comments, objections, or requests 

for any hearings will be accepted on any 

application for registration or reregistration to import raw opium and 

concentrate of poppy straw. As 

explained in the Correction to Notice of 

Application pertaining to Rhodes 

Technologies, 72 FR 3417 (2007), 

comments and requests for hearings on 

applications to import narcotic raw 

material are not appropriate. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic classes of controlled 

substances may file comments or 

objections to the issuance of the 

proposed registration and may, at the 

same time, file a written request for a 

hearing on such application pursuant to 

21 CFR 1301.43, and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than August 10, 2009. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substance in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: June 24, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–16296 Filed 7–8–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–314E] 

Established Assessment of Annual 

Needs for the List I Chemicals 

Ephedrine, Pseudoephedrine, and 

Phenylpropanolamine for 2009 

AGENCY: Drug Enforcement 

Administration (DEA), Justice. 

ACTION: Notice of Assessment of Annual 

Needs for 2009. 

SUMMARY: This notice establishes the 

initial 2009 Assessment of Annual 

Needs for certain List I chemicals in 

accordance with the Combat 

Methamphetamine Epidemic Act of 

2005 (CMEA), enacted on March 9, 

2006. 

DATES: Effective Date: August 10, 2009. 

FOR FURTHER INFORMATION CONTACT: 

Christine A. Sannerud, Ph.D., Chief, 

Drug and Chemical Evaluation Section, 

Drug Enforcement Administration, 8701 

Morrissette Drive, Springfield, Virginia 

22152, Telephone: (202) 307–7183. 

SUPPLEMENTARY INFORMATION: Section 

713 of the Combat Methamphetamine 

Epidemic Act of 2005 (Title VII of Pub. 

L. 109–177) (CMEA) amended Section 

306 of the Controlled Substances Act 

(CSA) (21 U.S.C. 826) by adding 

ephedrine, pseudoephedrine, and 

phenylpropanolamine to existing 

language to read as follows: ‘‘The 

Attorney General shall determine the 

total quantity and establish production 

quotas for each basic class of controlled 

substance in schedules I and II and for 

ephedrine, pseudoephedrine, and 

phenylpropanolamine to be 

manufactured each calendar year to 

provide for the estimated medical, 

scientific, research, and industrial needs 

of the United States, for lawful export 

requirements, and for the establishment 

and maintenance of reserve stocks.’’ 

Further, section 715 of CMEA amended 

21 U.S.C. 952 ‘‘Importation of controlled 

substances’’ by adding the same List I 

chemicals to the existing language in 

paragraph (a), and by adding a new 

paragraph (d) to read as follows: 

(a) Controlled substances in schedule I or 

II and narcotic drugs in schedule III, IV, or 

V; exceptions 

It shall be unlawful to import into the 

customs territory of the United States from 

any place outside thereof (but within the 

United States), or to import into the United 

States from any place outside thereof, any 

controlled substance in schedule I or II of 

subchapter I of this chapter, or any narcotic 

drug in schedule III, IV, or V of subchapter 

I of this chapter, or ephedrine, 

pseudoephedrine, and 

phenylpropanolamine, except that— 

(1) such amounts of crude opium, poppy 

straw, concentrate of poppy straw, and coca 

leaves, and of ephedrine, pseudoephedrine, 

and phenylpropanolamine, as the Attorney 

General finds to be necessary to provide for 

medical, scientific, or other legitimate 

purposes * * * may be so imported under 

such regulations as the Attorney General 

shall prescribe. 

* * * * * 

(d)(1) With respect to a registrant under 

section 958 who is authorized under 

subsection (a)(1) to import ephedrine, 

pseudoephedrine, or phenylpropanolamine, 

at any time during the year the registrant may 

apply for an increase in the amount of such 

chemical that the registrant is authorized to 

import, and the Attorney General may 

approve the application if the Attorney 

General determines that the approval is 

necessary to provide for medical, scientific, 

or other legitimate purposes regarding the 

chemical. 

Editor’s Note: This excerpt of the 

amendment is published for the convenience 

of the reader. The official text is published 

at 21 U.S.C. 952(a) and (d)(1). 

Background and Legal Authority 

Section 713 of the Combat 

Methamphetamine Epidemic Act of 

2005 (CMEA) (Title VII of Pub. L. 109– 

177) amended section 306 of the 

Controlled Substances Act (CSA) (21 


rmajette on DSK29S0YB1 with NOTICES